Functional characterization and evolution of the isotuberculosinol operon in Mycobacterium tuberculosis and related mycobacteria

Frontiers in Microbiology

Volumn 3, Issue OCT, 2012, Pages

  Mann, Francis M ^a,b   Xu, Meimei ^a   Davenport, Emily K ^a,c   Peters, Reuben J ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b WINONA STATE UNIVERSITY   (United States)

^c Washington State University   (United States)

Author keywords

Isoprenoid biosynthesis; Molecular evolution; Terpenoids; Virulence

Indexed keywords

EID: 84875792588     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00368     Document Type: Article

References (54)

1. Adam,P.,Hecht, S., Eisenreich, W., Kaiser, J., Grawert, T., Arigoni, D., etal. (2002). Biosynthesis of terpenes: studies on 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase. Proc. Natl. Acad. Sci. U.S.A. 99,12108-12113.
2. Bailey, A. M., Mahapatra, S., Brennan, P. J., and Crick, D. C. (2002). Identification, cloning, purification, and enzymatic characterization of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate synthase. Glycobiology 12, 813-820.
3. Becq, J., Gutierrez, M. C., Rosas-Magallanes, V., Rauzier, J., Gicquel, B., Neyrolles, O., etal. (2007). Contribution of horizontally acquired genomic islands to the evolution of the tubercle bacilli. Mol. Biol. Evol. 24,1861-1871.
4. Besra, G. S., Sievert, T., Lee, R. E., Slayden, R. A., Brennan, P. J., and Takayama, K. (1994). Identification of the apparent carrier in my colicacid synthesis.Proc.Natl.Acad.Sci.U.S.A. 91,12735-12739.
5. Brosch, R., Gordon, S. V., Garnier, T., Eiglmeier, K., Frigui, W., Valenti, P., etal. (2007). Genome plasticity of BCG and impact on vaccine efficacy. Proc. Natl. Acad. Sci. U.S.A. 104, 5596-5601.
6. Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K., etal. (2002). A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. U.S.A. 99, 3684-3689.
7. Burke, C., and Croteau, R. (2002). Interaction with the small subunit of geranyl diphosphate synthase modifies the chain length specificity of geranylgeranyl diphosphate synthase to produce geranyl diphosphate. J. Biol. Chem. 277, 3141-3149.
8. Camus, J. C., Pryor, M. J., Medigue, C., andCole,S.T. (2002). Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology 148, 2967-2973.
9. Cole, S. T., Brosch, R., Parkhill, J., Garnier,T.,Churcher,C.,Harris,D.,etal. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393,537-544.
10. Comas, I., Chakravartti, J., Small, P. M., Galagan, J., Niemann, S., Kremer, K., etal. (2010). Human T cell epitopesof Mycobacterium tuberculosis are evolutionarily hyper conserved. Nat. Genet. 42, 498-503.
11. Crick, D. C., Schulbach, M. C., Zink, E. E., Macchia, M., Barontini, S., Besra, G. S., etal. (2000). Polyprenyl phosphate biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatis. J. Bacteriol. 182, 5771-5778.
12. Daum, M., Herrmann, S., Wilkinson, B., and Bechthold, A. (2009). Genes and enzymes involved in bacterial isoprenoid biosynthesis. Curr. Opin. Chem. Biol. 13,180-188.
13. Dhiman,R.K.,Schulbach,M.C.,Mahapatra, S., Baulard, A. R., Vissa, V., Brennan, P. J., etal. (2004). Identification of a novel class of omega,E,E-farnesyl diphosphate synthase from Mycobacterium tuberculosis. J. Lipid Res. 45, 1140-1147.
14. Eoh, H., Brennan, P. J., and Crick, D. C. (2009). The Mycobacterium tuberculosis MEP (2C-methyl-derythritol 4-phosphate) pathway as a newdrugtarget.Tuberculosis(Edinb.) 89,1-11.
15. Fortune, S. M., Jaeger, A., Sarracino, D. A., Chase, M. R., Sassetti, C. M., Sherman, D. R., etal. (2005). Mutually dependent secretion of proteins required for mycobacterial virulence. Proc. Natl. Acad. Sci. U.S.A. 102, 10676-10681.
16. Garnier, T., Eiglmeier, K., Camus, J. C., Medina, N., Mansoor, H., Pryor,M.,etal. (2003). The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U.S.A. 100,7877-7882.
17. Hershberg,R.,Lipatov,M.,Small,P. M., Sheffer, H., Niemann, S., Homolka, S., etal. (2008). High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6, e311. doi: 10.1371/journal.pbio.0060311
18. Holsclaw, C. M., Sogi, K. M., Gilmore, S. A., Schelle, M. W., Leavell, M. D., Bertozzi, C. R., etal. (2008). Structural characterization of a novel sulfated menaquinone produced by stf3 from Mycobacterium tuberculosis. ACS Chem. Biol. 3, 619-624.
19. Hoshino, T., Nakano, C., Ootsuka, T., Shinohara, Y., and Hara, T. (2011). Substrate specificity of Rv3378c, an enzyme from Mycobacterium tuberculosis, and the inhibitory activity of the bicyclic diterpenoids against macrophage phagocytosis. Org. Biomol. Chem. 9, 2156-2165.
20. Hsieh, M. H., and Goodman, H. M. (2005). The Arabidopsis IspH homolog is involved in the plastid nonmevalonate pathway of isoprenoid biosynthesis. Plant Physiol. 138, 641-653.
21. Ichiyama, S., Shimokata, K., and Tsukamura, M. (1988). Relationship between mycobacterial species and their carotenoid pigments. Microbiol. Immunol. 32, 473-479.
22. Joshi, S. M., Pandey, A. K., Capite, N., Fortune, S. M., Rubin, E. J., and Sassetti, C. M. (2006). Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc. Natl. Acad. Sci. U.S.A. 103, 11760-11765.
23. Kaur,D.,Brennan,P. J.,and Crick,D. C. (2004). Decaprenyl diphosphate synthesis in Mycobacterium tuberculosis. J. Bacteriol. 186,7564-7570.
24. Mann, F. M., and Peters, R. J. (2012). Isotuberculosinol: the unusual case of an immunomodulatory diterpenoid from Mycobacterium tuberculosis. Med. Chem. Commun. 3, 899-904.
25. Mann, F. M., Prisic, S., Hu, H., Xu, M., Coates, R. M., and Peters,R.J. (2009a).Characterization and inhibition of a class II diterpene cyclase from Mycobacterium tuberculosis: implications for tuberculosis. J. Biol. Chem. 284, 23574-23579.
26. Mann, F. M., Thomas, J. A., and Peters, R. J. (2011a). Rv0989c encodes a novel (E)-geranyl diphosphate synthase facilitating decaprenyl diphosphate biosynthesis in Mycobacterium tuberculosis. FEBS Lett. 585,549-554.
27. Mann, F. M., Vanderven, B. C., and Peters, R. J. (2011b). Magnesium depletion triggers production of an immune modulating diterpenoid in Mycobacterium tuberculosis. Mol. Microbiol. 79,1594-1601.
28. Mann, F. M., Xu, M., Chen, X., Fulton, D. B., Russell, D. G., and Peters, R. J. (2009b). Edaxadiene: a new bioactive diterpene from Mycobacterium tuberculosis. J. Am. Chem. Soc. 131, 17526-17527.
29. Maugel, N., Mann, F. M., Hillwig, M. L., Peters, R. J., and Snider, B. B. (2010). Synthesis of(+/-)-nosyberkol(isotuberculosinol, revised structure of edaxadiene) and (+/-)-tuberculosinol. Org. Lett. 12,2626-2629.
30. McAteer, S., Coulson, A., Mclennan, N., and Masters, M. (2001). The lytB gene of Escherichia coli is essential and specifies a product needed for isoprenoid biosynthesis. J. Bacteriol. 183, 7403-7407.
31. Nakano, C., Okamura, T., Sato, T., Dairi, T., and Hoshino, T. (2005a). Mycobacterium tuberculosis H37Rv3377c encodes the diterpene cyclase for producing the halimane skeleton. Chem. Commun. 2005, 1016-1018.
32. Nakano, C., Ootsuka, T., Takayama, K., Mitsui, T., Sato, T., and Hoshino, T. (2011). Characterization of the Rv3378c gene product, a new diterpene synthase for producing tuberculosinol and (13R, S)-isotuberculosinol (nosyberkol), from the Mycobacterium tuberculosis H37Rv genome. Biosci. Biotechnol. Biochem. 75, 75-81.
33. Nakano, C., Sato, T., and Hoshino, T. (2005b). Structure of diterpene produced by Rv3378c gene product from Mycobacterium tuberculosis. Koryo Terupen oyobi Seiyu Kagaku ni kansuru Toronkai Koen Yoshishu 49, 247-249.
34. Obiol-Pardo, C., Rubio-Martinez, J., and Imperial, S. (2011). The methylerythritol phosphate (MEP) pathway for isoprenoid biosynthesis as a target for the development of new drugs against tuberculosis. Curr. Med. Chem. 18,1325-1338.
35. Pethe, K., Swenson, D. L., Alonso, S., Anderson, J., Wang, C., and Russell, D. G. (2004). Isolation of Mycobacterium tuberculosis mutants defective in the arrest of phagosome maturation. Proc. Natl.Acad. Sci. U.S.A. 101, 13642-13647.
36. Prach, L., Kirby, J., Keasling, J. D., and Alber, T. (2010). Diterpene production in Mycobacterium tuberculosis. FEBS J. 277, 3588-3595.
37. Reddy, T. B., Riley, R., Wymore, F., Montgomery, P., Decaprio, D., Engels, R., etal. (2009). TB database: an integrated platform for tuberculosis research. Nucleic Acids Res. 37, D499-D508.
38. Rohde, K., Yates, R. M., Purdy, G. E., and Russell, D. G. (2007). Mycobacterium tuberculosis and the environment with the phagosome. Immunol. Rev. 291, 37-54.
39. Rohdich, F., Hecht, S., Gartner, K., Adam, P., Krieger, C., Amslinger, S., etal. (2002). Studies on the nonmevalonate terpene biosynthetic pathway: metabolic role of IspH (LytB) protein. Proc. Natl. Acad. Sci. U.S.A. 99, 1158-1163.
40. Rohmer, M., Knani, M., Simonin, P., Sutter, B., and Sahm, H. (1993). Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochem. J. 295(Pt 2),517-524.
41. Russell, D. G. (2007). Who puts the tubercle in tuberculosis? Nat. Rev. Microbiol. 5,39-47.
42. Russell,D.G.,Barry,C.E.III,andFlynn, J. L. (2010). Tuberculosis: what we don't know can, and does, hurt us. Science 328,852-856.
43. Sassetti, C. M., Boyd, D. H., and Rubin, E. J. (2001). Comprehensive identificationofconditionallyessentialgenes inmycobacteria.Proc.Natl.Acad.Sci. U.S.A. 98, 12712-12717.
44. Sassetti, C. M., Boyd, D. H., and Rubin, E. J. (2003). Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48, 77-84.
45. Sassetti, C. M., and Rubin, E. J. (2003). Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. U.S.A. 100, 12989-12994.
46. Schmidt,A., and Gershenzon, J. (2008). Cloning and characterization of two different types of geranyl diphosphate synthases from Norway spruce (Picea abies). Phytochemistry 69, 49-57.
47. Schulbach, M. C., Brennan, P. J., and Crick, D. C. (2000). Identification of a short (C15) chain Z-isoprenyl diphosphate synthase and a homologous long (C50) chain isoprenyl diphosphate synthase in Mycobacteriumtuberculosis.J.Biol.Chem.275, 22876-22881.
48. Singh, N., Cheve, G., Avery, M. A., and Mccurdy, C. R. (2007). Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxyD-xylulose-5-phosphate reductoisomerase (DXR) enzyme. Curr. Pharm. Des. 13,1161-1177.
49. Sneath, P. H. A., and Sokal, R. R. (1973). Numerical Taxonomy: The Principles and Practice of Numerical Classification. San Francisco: W. H. Freeman.
50. Spangler, J. E., Carson, C. A., and Sorensen, E. J. (2010). Synthesis enables a structural revision of the Mycobacterium tuberculosis-produced diterpene, edaxadiene. Chem. Sci. 1, 202-205.
51. Stinear, T. P., Jenkin, G. A., Johnson, P. D., and Davies, J. K. (2000). Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence. J. Bacteriol. 182, 6322-6330.
52. Stinear, T. P., Seemann, T., Harrison, P. F., Jenkin, G. A., Davies, J. K., Johnson, P. D., etal. (2008). Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res. 18, 729-741.
53. Stinear, T. P., Seemann, T., Pidot, S., Frigui, W., Reysset, G., Garnier, T., etal. (2007). Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res. 17, 192-200.
54. Wolff, M., Seemann, M., Tse Sum Bui, B., Frapart, Y., Tritsch, D., Garcia Estrabot, A., etal. (2003). Isoprenoid biosynthesis via the methylerythritol phosphate pathway: the (E)-4-hydroxy-3-methylbut2-enyl diphosphate reductase (LytB/IspH) from Escherichia coli is a [4Fe-4S] protein. FEBS Lett. 541, 115-120.